Top-rated biotechs with negative enterprise values
Source: SeekingAlpha
2025-03-01 14:28:42 ET
More on iShares Biotechnology ETF, SPDR S&P Biotech ETF, etc.
- XBI: Diverse Holding Amid Strong Catalysts, Buy
- 2025 Analyst Outlook: Edmund Ingham On Biotech Big And Small, And A Key Milestone
- iShares Biotechnology ETF: Playing Defense
- Seeking Alpha’s Quant Rating on iShares Biotechnology ETF
- Dividend scorecard for iShares Biotechnology ETF
Read the full article on Seeking Alpha
For further details see:
Top-rated biotechs with negative enterprise values
Immatics N.V.
NASDAQ: IMTX
IMTX Trading
-0.61% G/L:
$11.37 Last:
87,110 Volume:
$11.48 Open:
IMTX Latest News
May 30, 2026 08:00:00 am
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
May 12, 2026 07:00:00 am
Immatics Announces First Quarter 2026 Financial Results and Business Update
IMTX Stock Data
$1,341,978,928
63,814,383
N/A
32
N/A
Biotechnology & Life Sciences
Healthcare
DE
Tbingen
